Oncoheroes has been featured on El Español, Spain's most-read digital newspaper. The article delves into the inspiring story of our co-founder, Ricardo García, and his dedicated mission to discover innovative therapies for childhood cancer. The narrative highlights Oncoheroes' ongoing initiatives aimed at raising funds to kickstart the clinical trial to test the efficacy of our lead-compound, Volasertib, on five pediatric cancer indications. Explore the full article and learn more about our journey by reading it here.
Oncoheroes Biosciences Featured in Expansion Newspaper after in-licensing two new clinic-ready assets
Oncoheroes has been featured at Expansión, an Economy and Investment Newspaper from Spain. The article highlights the in-licensing deal with Allarity Therapeutics (NASDAQ:ALLR) (see details here).
Oncoheroes Biosciences Featured in Expansion Newspaper after Out-licensing Volasertib
Oncoheroes has been featured at Expansión, an Economy and Investment Newspaper from Spain. The article highlights the out-licensing deal with Notable Labs (see details here).
Oncoheroes mentioned in EXPANSIÓN newspaper
Oncoheroes story and the investment news has been featured at the Spanish newspaper, Expansión.
Oncoheroes mentioned in El PERIODICO newspaper
Ricardo Garcia, Oncoheroes’ co-founder and CEO, was today interviewed at the Spanish newspaper, el Periódico.
Read more at El Periodico | Oct 29th, 2019
Oncoheroes mentioned in LA VANGUARDIA newspaper
Oncoheroes story has been featured at the Spanish newspaper, La Vanguardia, as one of our co-founders, Ricardo Garcia, is originally from Spain.
Read more at La Vanguardia | Oct 3rd, 2019
“Barcelona, 3 oct (EFE).- Dos padres con hijos con cáncer, uno de ellos un barcelonés que se trasladó a Boston (EEUU) para tratar la enfermedad de su hijo, han creado la startup biotecnológica Oncoheroes Biosciences Inc., que en menos de dos años de vida ya ha logrado 1,5 millones de euros para acelerar la fase clínica de un nuevo medicamento indicado para un cáncer pediátrico.“